Efficacy and Safety Study of MK0359 in Patients With Arthritis (0359-017)
NCT00482417 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 11
Last updated 2015-11-20
Summary
Efficacy and Safety Study of MK0359 in Patients with Arthritis
Conditions
Interventions
- DRUG
-
MK0359
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Medical Monitor · Merck Sharp & Dohme LLC
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-12-31
- Primary Completion
- 2003-05-31
- Completion
- 2003-05-31
More Related Trials
-
Drug Use Investigation for Humira® - All Patient Investigation for Rheumatoid Arthritis
NCT01076959 ·Status: COMPLETED
-
To Evaluate The Efficacy And Safety Of Sunpharma1505 Compared With Reference1505 In Subjects With Active Rheumatoid Arthritis
NCT02534896 ·Status: TERMINATED ·Phase: PHASE3
-
Study Evaluating Multiple Doses Of ATN-103 In Subjects With Active Rheumatoid Arthritis
NCT00959036 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Natrunix Versus Methotrexate in Rheumatoid Arthritis
NCT05363917 ·Status: UNKNOWN ·Phase: PHASE2
-
Safety and Efficacy of a Monoclonal Antibody for Treatment of Rheumatoid Arthritis.
NCT00034203 ·Status: COMPLETED ·Phase: PHASE2
-
Oral CF101 Tablets and Methotrexate Treatment in Rheumatoid Arthritis Patients
NCT00556894 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of TAK-715 in Subjects With Rheumatoid Arthritis
NCT00760864 ·Status: COMPLETED ·Phase: PHASE2
-
Phase I Study Of The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Multiple Intravenously Administered Doses Of PF-04236921 In Patients With Rheumatoid Arthritis
NCT00838565 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
NCT01225393 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of BMS-986195 in Healthy Male Subjects
NCT03245515 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of ACZ885 in Adult Patients With Established Rheumatoid Arthritis
NCT00504595 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate SC Route of Administration of Ofatumumab in RA Patients
NCT00686868 ·Status: COMPLETED ·Phase: PHASE1
-
Leflunomide + Methotrexate in Rheumatoid Arthritis
NCT00563849 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Assess the Safety and Tolerability of MEDI5117 in Rheumatoid Arthritis Patients
NCT01559103 ·Status: TERMINATED ·Phase: PHASE1
-
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of SHR-3045 in Healthy Subjects
NCT07200596 ·Status: RECRUITING ·Phase: PHASE1
-
A Phase I Rheumatoid Arthritis Study in Healthy Volunteers
NCT00539760 ·Status: COMPLETED ·Phase: PHASE1
-
Study Of The Safety Of CE 224,545 And Methotrexate In Patients With Rheumatoid Arthritis
NCT00446784 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK3117391 in Subjects With Rheumatoid Arthritis
NCT02965599 ·Status: TERMINATED ·Phase: PHASE2
-
Safety, Tolerability and Relative Bioavailability Study of BMS-986195 in Healthy Subjects
NCT02705989 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase Ⅰ Clinical Trial to Evaluate the Safety, Tolerance, Pharmacokinetics and Pharmacodynamics of SHR-3045 in Healthy Subjects
NCT06883695 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Phase IIb Study of Evobrutinib in Subjects With Rheumatoid Arthritis
NCT03233230 ·Status: COMPLETED ·Phase: PHASE2
-
A 2-Year Phase 3 Study Of CP-690,550 In Patients With Active Rheumatoid Arthritis On Background Methotrexate
NCT00847613 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Abatacept in Patients With Early Rheumatoid Arthritis
NCT02504268 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severely Active Psoriatic Arthritis Subjects With Inadequate Response to Disease Modifying Anti-Rheumatic Drug Therapy
NCT00646178 ·Status: COMPLETED ·Phase: PHASE3
-
COX-2 Inhibitor Study In Patients With Rheumatoid Arthritis
NCT00113308 ·Status: COMPLETED ·Phase: PHASE3